KEGG enrichment analysis further revealed that shikonin suppressed key tumorigenesis-related pathways, including the mTOR signaling pathway and pathways implicated in cancer and breast cancer (Figure 3C). The gene discussed is MTOR; the disease is breast carcinoma.